This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Incyte Corporation. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: The Innovative Contributions of Brandon Smith
Introduction
Brandon Smith is a notable inventor based in Chadds Ford, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of two patents to his name, Smith's work focuses on developing innovative compounds that target specific biological pathways.
Latest Patents
Brandon Smith's latest patents include imidazolyl pyrimidinylamine compounds as CDK2 inhibitors. These patents provide inhibitors of cyclin-dependent kinase 2 (CDK2), along with pharmaceutical compositions and methods for treating cancer. His research aims to enhance the efficacy of cancer therapies through targeted inhibition of this critical enzyme.
Career Highlights
Smith is currently employed at Incyte Corporation, a leading biopharmaceutical company. His role involves extensive research and development in the area of oncology, where he applies his expertise to create novel therapeutic solutions. His contributions have been instrumental in advancing the company's mission to improve patient outcomes.
Collaborations
Some of Brandon Smith's coworkers include Qinda Ye and Jingwei Li. Their collaborative efforts in research have fostered a productive environment that encourages innovation and scientific discovery.
Conclusion
Brandon Smith's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents and research efforts contribute significantly to the ongoing fight against cancer, showcasing the importance of targeted therapies in modern medicine.